Skip to main content
. 2019 Jul 24;2019:3515080. doi: 10.1155/2019/3515080

Figure 1.

Figure 1

Representative 18F-FDG PET images of a responder and a nonresponder with osteosarcoma. Responder SUVmax values were 11.33 and 4.43 at baseline and after neoadjuvant chemotherapy (NAC), respectively. Nonresponders had SUVmax values of 5.62 and 3.21 at baseline and after NAC, respectively.